Pamela Tenaerts

Tenaerts Pamela.png

Dr. Tenaerts is the Executive Director at the Clinical Trials Transformation Initiative (CTTI) where she works closely with the Executive Committee to develop and implement strategies to accomplish CTTI’s mission. She provides senior level oversight of the day-to-day operations of CTTI and orchestrates efforts to effectively engage all interested stakeholders to improve the conduct of clinical trials. She is on the Board of Directors for the Society of Clinical Trials and a member of the Advisory Council North America, DIA; PCORI's CTAP Expert Post-award Subcommittee; and MIT’s Collaborative Initiatives Clinical Trials Process Expert Advisory Board.

With more than 20 years’ experience in the clinical trials enterprise across a number of sectors, Dr. Tenaerts practiced medicine in both the emergency department and private practice setting before embarking on a career in research. Prior to CTTI, she oversaw European operations for CoAxia, a medical device company focused on cerebral ischemia. Dr. Tenaerts received her MD from Catholic University of Leuven, Belgium, and a MBA from the University of South Florida. She speaks five languages and has obtained Six Sigma Green Belt certification.